Coloplast
| Company type | Publicly traded Aktieselskab |
|---|---|
| Nasdaq Copenhagen: COLO B | |
| Industry | Health care |
| Founded | 1957 |
| Founder | Aage Louis-Hansen |
| Headquarters | , |
Key people | Lars Rasmussen (Interim CEO) Niels Peter Louis-Hansen (Deputy chairman) |
| Products | Ostomy bags, continence products, urology products, wound dressings |
| Revenue | DKK18.544 billion (2019/2020) |
| DKK5.854 billion (2020/2021, before special items) | |
| Total assets | DKK13.499 billion (September 2021) |
| Total equity | DKK5.928 billion (September 2021) |
Number of employees | 12,500 (FTE, September 2021) |
| Website | www.coloplast.com |
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care.